ITGAX and neoplasm: Flow cytometry analysis of myeloid cells showed that SKI-G-801 treatment increased the number of M1-like macrophages (F4/80+CD206+CD11c-) and total macrophages (CD45+F4/80+) in the TC1 tumor model (*p<0.05, **p<0.01) (Figure 4A).